Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221

NCT02146066 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

GBM
Glioblastoma Multiforme

Interventions

BIOLOGICAL: DCVax-L

Sponsor

Northwest Biotherapeutics